Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion

被引:62
|
作者
Barber, DF
Bartolomé, A
Hernandez, C
Flores, JM
Fernandez-Arias, C
Rodríguez-Borlado, L
Hirsch, E
Wymann, M
Balomenos, D
Carrera, AC
机构
[1] Univ Autonoma Madrid, Dept Immunol & Oncol, E-28049 Madrid, Spain
[2] Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Anim Facil, E-28049 Madrid, Spain
[3] Univ Complutense Madrid, Sch Vet, Dept Anim Med & Surg, E-28040 Madrid, Spain
[4] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy
[5] Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland
来源
JOURNAL OF IMMUNOLOGY | 2006年 / 176卷 / 01期
关键词
D O I
10.4049/jimmunol.176.1.589
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Class I PI3K catalyzes formation of 3-poly-phosphoinositides. The family is divided into I-A isoforms, activated by Tyr kinases and I-A the I-B isoform (PI3K gamma), activated by G protein-coupled receptors. Mutations that affect PI3K are implicated in chronic inflammation, although the differential contribution of each isoform to pathology has not been elucidated. Enhanced activation of class I-A-PI3K in T cells extends CD4(+) memory cell survival, triggering an invasive lymphoproliferative disorder and systemic lupus. As both I-A- and 1(B)-PI3K isoforms regulate T cell activation, and activated pathogenic CD4(+) memory cells are involved in triggering systemic lupus, we examined whether deletion of I-B could reduce the pathological consequences of increased I-A-PI3K activity. I-B-PI3K gamma deficiency did not abolish invasion or lymphoproliferation, but reduced CD4(+) memory cell survival, autoantibody production, glomerulonephritis, and systemic lupus. Deletion of the I-B-PI3K gamma isoform thus decreased survival of pathogenic CD4(+) memory cells, selectively inhibiting systemic lupus development. These results validate the PI3K gamma isoform as a target for systemic lupus erythernatosus treatment.
引用
收藏
页码:589 / 593
页数:5
相关论文
共 50 条
  • [1] Phosphatidylinositol 3-kinase (PI3K) inhibitors as anticancer drugs
    Verheijen, Jeroen C.
    Zask, Arie
    DRUGS OF THE FUTURE, 2007, 32 (06) : 537 - 547
  • [2] Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
    Akinleye, Akintunde
    Avvaru, Parthu
    Furqan, Muhammad
    Song, Yongping
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [3] Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
    Akintunde Akinleye
    Parthu Avvaru
    Muhammad Furqan
    Yongping Song
    Delong Liu
    Journal of Hematology & Oncology, 6
  • [4] Blockade of Phosphatidylinositol 3-Kinase (PI3K)δ or PI3Kγ Reduces IL-17 and Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis
    Roller, Anne
    Perino, Alessia
    Dapavo, Paolo
    Soro, Elisabetta
    Okkenhaug, Klaus
    Hirsch, Emilio
    Ji, Hong
    JOURNAL OF IMMUNOLOGY, 2012, 189 (09): : 4612 - 4620
  • [5] Binding and selectivity studies of phosphatidylinositol 3-kinase (PI3K) inhibitors
    Al Hasan, Mohammad
    Sabirianov, Matthew
    Redwine, Grace
    Goettsch, Kaitlin
    Yang, Stephen X.
    Zhong, Haizhen A.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2023, 121
  • [6] Inhibition of phosphatidylinositol 3-kinase α (PI3Kα) prevents heterotopic ossification
    Antonio Valer, Jose
    Sanchez-de-Diego, Cristina
    Gamez, Beatriz
    Mishina, Yuji
    Luis Rosa, Jose
    Ventura, Francesc
    EMBO MOLECULAR MEDICINE, 2019, 11 (09)
  • [7] Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
    Margaret A. Knowles
    Fiona M. Platt
    Rebecca L. Ross
    Carolyn D. Hurst
    Cancer and Metastasis Reviews, 2009, 28 : 305 - 316
  • [8] Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
    Knowles, Margaret A.
    Platt, Fiona M.
    Ross, Rebecca L.
    Hurst, Carolyn D.
    CANCER AND METASTASIS REVIEWS, 2009, 28 (3-4) : 305 - 316
  • [9] ALPELISIB Phosphatidylinositol 3-kinase alpha (PI3Kα) inhibitor Oncolytic
    Heymann, M-F.
    Renema, N.
    Heymann, D.
    DRUGS OF THE FUTURE, 2015, 40 (04) : 213 - 223
  • [10] Phosphatidylinositol 3-kinase (PI3K) signaling and regulation of the antibody response
    Omori, Sidne A.
    Rickert, Robert C.
    CELL CYCLE, 2007, 6 (04) : 397 - 402